The effect of pioglitazone on circulating interleukin-10 and tumor necrosis factor-alpha levels in a patient with metabolic syndrome: A randomized, double-blind controlled trial

BACKGROUND: This study aimed to evaluate the effect of pioglitazone as an insulin sensitizer on circulating interleukin-10 (IL-10) as an anti-inflammatory factor and tumor necrosis factor-alpha (TNF-α) as main proinflammatory factor in non-diabetic metabolic syndrome (MetS) patients in Caucasians ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourmoghaddas, Ali, Dormiani-Tabatabaei, Mehrnaz, Sadeghi, Masoumeh, Kermani-Alghoraishi, Mohammad, Golshahi, Jafar, Shokouh, Pedram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Isfahan Cardiovascular Research Center, Isfahan University of Medical Sciences 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460351/
https://www.ncbi.nlm.nih.gov/pubmed/26089929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460351/
https://www.ncbi.nlm.nih.gov/pubmed/26089929

Ejemplares similares